Jeff Yass’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Jeff Yass’s Portfolio AXN Stock Details AXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-44,083	Closed	-$7K	–	10405
2017 Q3	$7K	Sell	44,083 -14,822	-25%	-$4.04K	﹤0.01%	8701
2017 Q2	$18K	Sell	58,905 -44,114	-43%	-$16K	﹤0.01%	9041
2017 Q1	$42K	Buy	103,019 +46,435	+82%	+$20K	﹤0.01%	8628
2016 Q4	$18K	Sell	56,584 -88,445	-61%	-$36.6K	﹤0.01%	9441
2016 Q3	$80K	Buy	+145,029	New	+$97.5K	﹤0.01%	8017
2015 Q2	–	Sell	-30,465	Closed	-$51K	–	10699
2015 Q1	$51K	Buy	+30,465	New	+$28.4K	﹤0.01%	9148
2014 Q2	–	Sell	-10,328	Closed	-$4K	–	10329
2014 Q1	$4K	Buy	+10,328	New	+$3.69K	﹤0.01%	8811

Jeff Yass's AXN Position: Q4 2017 in Review

Jeff Yass sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2017, closing a stake of 44,083 shares — an estimated $7K sold.

Jeff Yass first reported a position in AXN in Q1 2014 and held it in 7 quarters. The position peaked at $80K in Q3 2016. 0 funds tracked by Wall St. Rank hold AXN as of Q4 2017.

Jeff Yass reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2017 after selling out during the quarter.
Jeff Yass sold 44,083 Aoxing Pharmaceutical Company Inc. shares in Q4 2017, an estimated $7K.
Jeff Yass first reported a position in Aoxing Pharmaceutical Company Inc. in Q1 2014 and held it in 7 quarters.
Jeff Yass's Aoxing Pharmaceutical Company Inc. position peaked at $80K in Q3 2016.
0 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2017.

Based on Susquehanna International Group's 13F filing for Q4 2017, filed 14 Feb 2018.